Evidence map›Paper›PMID 39177855›Full record

ArticleEuropean radiology2025

Renal tumor segmentation, visualization, and segmentation confidence using ensembles of neural networks in patients undergoing surgical resection.

Sophie Bachanek, Paul Wuerzberg, Lorenz Biggemann, Tanja Yani Janssen, Manuel Nietert, Joachim Lotz, Philip Zeuschner, Alexander Maßmann, Annemarie Uhlig, Johannes Uhlig

Abstract read
In one paragraph

Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sophie BachanekDepartment of Clinical and Interventional Radiology, University Medical Center Goettingen, Goettingen, Germany.
Paul WuerzbergDepartment of Medical Bioinformatics, University Medical Center Goettingen, Goettingen, Germany.
Lorenz BiggemannDepartment of Clinical and Interventional Radiology, University Medical Center Goettingen, Goettingen, Germany.
Tanja Yani JanssenDepartment of Clinical and Interventional Radiology, University Medical Center Goettingen, Goettingen, Germany.
Manuel NietertDepartment of Medical Bioinformatics, University Medical Center Goettingen, Goettingen, Germany.
Joachim LotzDepartment of Cardiac Radiology, University Medical Center Goettingen, Goettingen, Germany.
Philip ZeuschnerDepartment of Urology and Pediatric Urology, Saarland University, Homburg, Germany.
Alexander MaßmannDepartment of Radiology & Nuclear Medicine, Robert-Bosch-Krankenhaus, Bosch Health Campus, Stuttgart, Germany.
Annemarie UhligDepartment of Urology, University Medical Center Goettingen, Goettingen, Germany.
Johannes UhligDepartment of Clinical and Interventional Radiology, University Medical Center Goettingen, Goettingen, Germany. johannes.uhlig@med.uni-goettingen.de.ORCID http://orcid.org/0000-0003-3557-3194

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo develop an automatic segmentation model for solid renal tumors on contrast-enhanced CTs and to visualize segmentation with associated confidence to promote clinical applicability. MATERIALS AND

methodsThe training dataset included solid renal tumor patients from two tertiary centers undergoing surgical resection and receiving CT in the corticomedullary or nephrogenic contrast media (CM) phase. Manual tumor segmentation was performed on all axial CT slices serving as reference standard for automatic segmentations. Independent testing was performed on the publicly available KiTS 2019 dataset. Ensembles of neural networks (ENN, DeepLabV3) were used for automatic renal tumor segmentation, and their performance was quantified with DICE score. ENN average foreground entropy measured segmentation confidence (binary: successful segmentation with DICE score > 0.8 versus inadequate segmentation ≤ 0.8).

resultsN = 639/n = 210 patients were included in the training and independent test dataset. Datasets were comparable regarding age and sex (p > 0.05), while renal tumors in the training dataset were larger and more frequently benign (p < 0.01). In the internal test dataset, the ENN model yielded a median DICE score = 0.84 (IQR: 0.62-0.97, corticomedullary) and 0.86 (IQR: 0.77-0.96, nephrogenic CM phase), and the segmentation confidence an AUC = 0.89 (sensitivity = 0.86; specificity = 0.77). In the independent test dataset, the ENN model achieved a median DICE score = 0.84 (IQR: 0.71-0.97, corticomedullary CM phase); and segmentation confidence an accuracy = 0.84 (sensitivity = 0.86 and specificity = 0.81). ENN segmentations were visualized with color-coded voxelwise tumor probabilities and thresholds superimposed on clinical CT images.

conclusionsENN-based renal tumor segmentation robustly performs in external test data and might aid in renal tumor classification and treatment planning. CLINICAL RELEVANCE STATEMENT: Ensembles of neural networks (ENN) models could automatically segment renal tumors on routine CTs, enabling and standardizing downstream image analyses and treatment planning. Providing confidence measures and segmentation overlays on images can lower the threshold for clinical ENN implementation. KEY POINTS: Ensembles of neural networks (ENN) segmentation is visualized by color-coded voxelwise tumor probabilities and thresholds. ENN provided a high segmentation accuracy in internal testing and in an independent external test dataset. ENN models provide measures of segmentation confidence which can robustly discriminate between successful and inadequate segmentations.

Indexed as

Kidney NeoplasmsNeural Networks, ComputerRadiographic Image Interpretation, Computer-AssistedTomography, X-Ray ComputedAdultAgedContrast MediaFemaleHumansMaleMiddle AgedRetrospective StudiesContrast MediaDeep learning tumor segmentationEnsembles of neural networksKidney tumor segmentationRenal tumor segmentationSemantic segmentation

Identifiers

PMID39177855
PMCPMC11913914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.